Marchant Quoted in CLINICAL OMICs

Gary Marchant, ASU Regents’ Professor of Law and Director of the Center for Law, Science & Innovation‘s GET Program, was recently quoted in a Clinical Omics report on human genome-based medicine.  Tremendous strides have been made in the application of genetic information to gain insight into health conditions, medical treatments and drug responses.  However, the infrastructure that the genomics enterprise is built upon and around requires upgrading.  One structural element that is often cited when dealing with new technologies is the regulatory scheme.  Marchant points out one of the many frictions that may arise when contemporary technological methods are required to be subjected to, or operate within, the confines of an archaic, ill-fitting, legal framework.   Other hurdles include training, education, privacy, data security and effective policy.  For more on this discussion, click here.